Results 191 to 200 of about 840,940 (292)

Neuroradiologic-pathologic correlation in a neurenteric cyst of the clivus.

, 2002
Vibhu Kapoor, D. Johnson, Melanie B. Fukui, William E. Rothfus, Hae Dong Jho   +4 more
openalex   +1 more source

Sequential pathological study of spontaneous testicular degeneration in WBN/Kob rats.

, 1991
Motonobu Sato, Kazutoshi Shinoda, Fumio Furukawa, Takayoshi Imazawa, Hiroyuki Yoshimura, Kunitoshi Mitsumori, Michihito Takahashi   +6 more
openalex   +2 more sources

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Clinical stage II non-small cell lung cancer: can we "just give adjuvant therapy"? [PDF]

J Thorac Dis
Jindani R, Loh I, Rodriguez-Quintero JH, Ha G, Rosario J, Cohen B, Nobel TB, Vimolratana M, Chudgar NP, Stiles BM.   +9 more
europepmc   +1 more source

HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice [PDF]

, 2017
Esser, Alison K, et al,, Harding, John C, Ratner, Lee, Rauch, Daniel A, Ross, Michael H, Su, Xinming, Vij, Kiran, Weilbaecher, Katherine N, Wu, Kevin, Xiang, Jingyu, Xu, Yalin   +11 more
core   +2 more sources

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Prognostic Impact of Radiologic and Pathologic Features on the Development of Progressive Pulmonary Fibrosis in Patients With Interstitial Lung Disease Other Than Idiopathic Pulmonary Fibrosis. [PDF]

Korean J Radiol
Cho HR, Chung MJ, Choi H, Kim J, An AR, Ahn SY, Yoo JY, Jin GY, Lynch DA, Chae KJ.   +9 more
europepmc   +1 more source

A Case of an Invasive Lobular Carcinoma with Extracellular Mucin: Radio-Pathological Correlation

, 2017
Shinya Tajima, Keiko Kishimoto, Yoshihide Kanemaki, Ichiro Maeda, Akira Endo, Motohiro Chosokabe, Takafumi Ono, Koichiro Tsugawa, Masayuki Takagi   +8 more
openalex   +2 more sources

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source

Efficacy and safety of the neoadjuvant chemoimmunotherapy with pembrolizumab plus docetaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck. [PDF]

Front Immunol
Wang J, Zhang W, Huang D, Liu Z, Zhang W, Li Z.   +5 more
europepmc   +1 more source